Reinforcement Intervention for HIV Testing
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether rewards can encourage more women to undergo HIV testing. It targets African American and Latina women, as well as those living in poverty, who may face higher HIV risks due to factors like drug use or partners with unknown HIV status. The trial compares two groups: one receives standard testing referrals and education, while the other also receives financial incentives for testing. Women who identify as African American or Latina, live in poverty, and have at least one HIV risk factor may be suitable for this trial. The goal is to determine if rewards increase testing rates and aid in early HIV detection. As an unphased trial, this study provides a unique opportunity to understand how incentives might improve health outcomes.
Do I have to stop taking my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on increasing HIV testing rather than medication changes.
What prior data suggests that this reinforcement intervention is safe for increasing HIV testing?
Research has shown that rewards can safely and effectively encourage people to adopt healthy habits, such as getting tested for HIV. Past studies used incentives, like money, without major safety issues. Participants generally receive these reward-based methods well, and they carry little risk.12345
Why are researchers excited about this trial?
Researchers are excited about the Reinforcement Intervention for HIV Testing trial because it explores a unique approach to encouraging HIV testing. Unlike standard methods that simply refer individuals for testing, this trial adds an element of reinforcement to standard referral and online HIV risk reduction training. This reinforcement involves additional encouragement and support, which could potentially increase the likelihood of individuals following through with testing. By focusing on behavioral reinforcement, this approach aims to improve testing rates and engagement, which is crucial for early detection and management of HIV.
What evidence suggests that this trial's treatments could be effective for increasing HIV testing among high-risk women?
This trial will compare different approaches to increase HIV testing rates. Participants in Treatment Group A will receive a standard referral for HIV testing along with online HIV risk reduction training. Participants in Treatment Group B will receive the same standard referral and online training, but with additional reinforcement. Research has shown that certain methods, such as offering incentives or providing personalized and emotionally engaging programs, effectively increase the number of people getting tested for HIV. These methods help people understand the importance of knowing their HIV status and motivate them to get tested.12567
Who Is on the Research Team?
Kristyn Zajac, Ph.D.
Principal Investigator
UConn Health
Are You a Good Fit for This Trial?
This trial is for African American, Latina, and women living in poverty who are at high risk for HIV. Participants must be female, speak English or Spanish, work with high-risk women as a case manager or clinician, have not had a recent HIV test or are not already HIV positive, and plan to stay employed at their agency.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive standard referral for HIV testing and online HIV risk reduction training, with reinforcement for testing in the experimental group
Follow-up
Participants are monitored for HIV testing completion and other outcomes at 3-, 9-, and 15-month intervals
What Are the Treatments Tested in This Trial?
Interventions
- Online risk reduction training
- Reinforcement
- Standard referral for HIV testing
Find a Clinic Near You
Who Is Running the Clinical Trial?
UConn Health
Lead Sponsor
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator